Insights

Watch a practical session exploring how biomethane can help tackle both your scope 1 and scope 3 decarbonisation efforts.

CBAM is no longer just a reporting requirement; it is a measurable cost for every imported good

Watch a practical session exploring how the pharmaceutical industry can accelerate decarbonisation that matters most through innovative clean energy strategies.

Learn how 3Degrees helped a data centre operator navigate emerging regulatory environments and source biomethane.

Make sense of the forces shaping today’s renewable energy landscape.

How to build a procurement strategy that pays for itself

Counting Emissions Won’t Cut Them

Learn why pharma companies should rely on biomethane as a scalable, credible, and readily available low-carbon solution to address their scope 1 footprint.

To meet ambitious climate goals, businesses need to invest in high-quality carbon removals—before it's too late.

As businesses work to address residual emissions, biochar has emerged as a key CDR solution.